Schaper Benz & Wise Investment Counsel’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.9M Buy
49,206
+61
+0.1% +$34.2K 1.73% 16
2026
Q1
$27.6M Sell
49,145
-353
-0.7% -$226K 2.11% 11
2025
Q4
$33.5M Sell
49,498
-57
-0.1% -$38.8K 2.42% 9
2025
Q3
$31.7M Sell
49,555
-618
-1% -$375K 2.35% 10
2025
Q2
$26.9M Buy
50,173
+339
+0.7% +$162K 2.06% 12
2025
Q1
$20.9M Buy
49,834
+5,332
+12% +$2.32M 1.7% 20
2024
Q4
$18.4M Buy
44,502
+3,400
+8% +$1.49M 1.48% 24
2024
Q3
$20.8M Buy
41,102
+1,598
+4% +$776K 1.66% 18
2024
Q2
$19.2M Sell
39,504
-671
-2% -$337K 1.67% 21
2024
Q1
$21.7M Buy
40,175
+222
+0.6% +$121K 1.81% 16
2023
Q4
$22.2M Buy
39,953
+159
+0.4% +$74.6K 2.01% 13
2023
Q3
$17.4M Buy
39,794
+112
+0.3% +$55.9K 1.72% 19
2023
Q2
$19.9M Sell
39,682
-2
-0% -$958 1.91% 15
2023
Q1
$19.8M Sell
39,684
-299
-0.7% -$143K 2.01% 15
2022
Q4
$16.3M Sell
39,983
-634
-2% -$246K 1.73% 21
2022
Q3
$13.2M Sell
40,617
-317
-0.8% -$116K 1.53% 25
2022
Q2
$14.4M Buy
40,934
+569
+1% +$232K 1.48% 28
2022
Q1
$22.1M Sell
40,365
-596
-1% -$314K 1.9% 14
2021
Q4
$27M Sell
40,961
-134
-0.3% -$84.1K 2.17% 7
2021
Q3
$25.6M Sell
41,095
-530
-1% -$356K 2.29% 7
2021
Q2
$26.3M Sell
41,625
-2,826
-6% -$1.56M 2.37% 7
2021
Q1
$21.8M Sell
44,451
-1,345
-3% -$674K 2.12% 12
2020
Q4
$22.9M Sell
45,796
-2,098
-4% -$939K 2.37% 8
2020
Q3
$18.8M Sell
47,894
-966
-2% -$357K 2.19% 12
2020
Q2
$16.1M Sell
48,860
-1,896
-4% -$549K 2% 15
2020
Q1
$12.3M Buy
50,756
+294
+0.6% +$76.7K 1.79% 21
2019
Q4
$13.2M Sell
50,462
-479
-0.9% -$126K 1.54% 28
2019
Q3
$13.9M Sell
50,941
-862
-2% -$240K 1.73% 25
2019
Q2
$14.3M Buy
51,803
+433
+0.8% +$107K 1.8% 22
2019
Q1
$11.5M Buy
51,370
+410
+0.8% +$84.6K 1.49% 28
2018
Q4
$9.48M Sell
50,960
-349
-0.7% -$71.6K 1.42% 32
2018
Q3
$12.8M Sell
51,309
-3,506
-6% -$851K 1.71% 26
2018
Q2
$11.9M Sell
54,815
-715
-1% -$147K 1.71% 25
2018
Q1
$10.6M Sell
55,530
-1,940
-3% -$358K 1.57% 28
2017
Q4
$8.99M Buy
57,470
+430
+0.8% +$67.7K 1.31% 34
2017
Q3
$8.87M Sell
57,040
-910
-2% -$144K 1.38% 34
2017
Q2
$9.35M Buy
57,950
+3,400
+6% +$552K 1.5% 31
2017
Q1
$8.43M Sell
54,550
-50
-0.1% -$6.89K 1.43% 31
2016
Q4
$6.4M Sell
54,600
-275
-0.5% -$31.4K 1.14% 40
2016
Q3
$6.19M Sell
54,875
-700
-1% -$73.8K 1.09% 39
2016
Q2
$5.16M Sell
55,575
-100
-0.2% -$8.59K 0.93% 44
2016
Q1
$4.36M Buy
55,675
+4,220
+8% +$304K 0.82% 49
2015
Q4
$3.75M Buy
51,455
+1,370
+3% +$97.7K 0.74% 50
2015
Q3
$3.72M Buy
50,085
+1,190
+2% +$85.2K 0.75% 49
2015
Q2
$3.14M Buy
48,895
+17,855
+58% +$1.24M 0.62% 52
2015
Q1
$2.4M Sell
31,040
-40
-0.1% -$3.11K 0.47% 55
2014
Q4
$2.3M Buy
31,080
+280
+0.9% +$19.6K 0.46% 56
2014
Q3
$1.81M Buy
30,800
+300
+1% +$19K 0.38% 59
2014
Q2
$2.04M Sell
30,500
-200
-0.7% -$12.7K 0.42% 54
2014
Q1
$1.86M Hold
30,700
0.4% 53
2013
Q4
$1.63M Buy
30,700
+50
+0.2% +$2.63K 0.36% 54
2013
Q3
$1.53M Buy
30,650
+1,100
+4% +$52.9K 0.35% 55
2013
Q2
$1.32M Buy
+29,550
New +$1.29M 0.33% 56

Other funds holding IDXX

Schaper Benz & Wise Investment Counsel's IDXX Position: Q2 2026 in Review

Schaper Benz & Wise Investment Counsel increased its Idexx Laboratories (IDXX) stake by 0.12% in Q2 2026, buying an estimated $34.2K and bringing the position to 49,206 shares worth $25.9M. The position accounts for 1.73% of the portfolio, ranked #16.

Schaper Benz & Wise Investment Counsel first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $33.5M in Q4 2025. 509 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Schaper Benz & Wise Investment Counsel held 49,206 shares of Idexx Laboratories worth $25.9M as of Q2 2026.
  • Schaper Benz & Wise Investment Counsel bought 61 Idexx Laboratories shares in Q2 2026, an estimated $34.2K.
  • Idexx Laboratories made up 1.73% of Schaper Benz & Wise Investment Counsel's portfolio in Q2 2026, its #16 holding.
  • Schaper Benz & Wise Investment Counsel first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Schaper Benz & Wise Investment Counsel's Idexx Laboratories position peaked at $33.5M in Q4 2025.
  • 509 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Schaper Benz & Wise Investment Counsel's 13F filing for Q2 2026, filed 21 Jul 2026.